Heart-Lung Machines

Global Heart-Lung Machines Market to Reach US$3.1 Billion by 2030

The global market for Heart-Lung Machines estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Oxygenators Component, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$892.9 Million by the end of the analysis period. Growth in the Pumps Component segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$635.4 Million While China is Forecast to Grow at 8.1% CAGR

The Heart-Lung Machines market in the U.S. is estimated at US$635.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$651.7 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Heart-Lung Machines Market - Key Trends and Drivers Summarized

How Are Heart-Lung Machines Integral to Modern Cardiac Surgery?

Heart-lung machines are vital to modern cardiac surgery, playing a crucial role in supporting patients` cardiac and respiratory functions during complex procedures such as heart valve repair or replacement, coronary artery bypass grafting, and major aortic surgery. These machines temporarily take over the functions of the heart and lungs, circulating and oxygenating the blood outside the patient`s body. This allows surgeons to operate on a still and bloodless heart, providing the precision necessary for intricate heart surgeries. The ability to maintain the circulation of oxygen-rich blood throughout the body during surgery minimizes the risk of organ damage and allows for longer, more complex procedures to be performed with greater safety. The evolution of heart-lung machine technology, including better oxygenators and more sophisticated monitoring systems, has significantly increased the safety and efficacy of cardiac surgeries, improving patient outcomes.

What Innovations Are Enhancing the Functionality of Heart-Lung Machines?

Recent innovations in heart-lung machine technology are focused on enhancing safety, efficiency, and patient compatibility. Advances include the development of more sophisticated oxygenators that more efficiently oxygenate the blood while being gentler on blood cells, reducing the risk of hemolysis and other complications. Automated systems that can adjust flow rates and pressures in real-time based on continuous monitoring of the patient`s vital signs are also being integrated, enhancing the precision and responsiveness of the machine to the patient`s immediate needs. Furthermore, the use of biocompatible materials in the components of heart-lung machines minimizes the risk of adverse reactions, such as inflammation or clotting, improving overall biocompatibility and patient safety. These technological advancements not only improve the functionality of heart-lung machines but also expand the range of cardiac procedures that can be safely performed.

How Do Heart-Lung Machines Impact Patient Outcomes and Healthcare Costs?

Heart-lung machines have a profound impact on patient outcomes and healthcare costs by enabling life-saving cardiac surgeries with higher success rates and lower risks of complications. By supporting vital bodily functions during surgery, these machines allow for longer and more complex procedures with improved outcomes, which can significantly extend life expectancy and quality of life for patients with severe cardiac conditions. The reliability and precision of modern heart-lung machines also reduce the likelihood of intraoperative complications, which can lead to shorter ICU stays and faster recovery times, thereby decreasing overall healthcare costs associated with postoperative care and hospitalization. Additionally, the ability to perform these critical surgeries safely reduces long-term healthcare spending by preventing the progression of cardiac diseases and avoiding the need for repeated interventions.

What Trends Are Driving Growth in the Heart-Lung Machine Market?

Several key trends are driving growth in the heart-lung machine market, including the aging global population, increasing prevalence of cardiovascular diseases, and advances in surgical techniques and technologies. As the global population ages, the incidence of cardiovascular conditions that require surgical intervention, such as coronary artery disease and heart valve defects, is increasing. This demographic shift is driving demand for cardiac surgeries and, consequently, for heart-lung machines. Additionally, advancements in surgical techniques, including minimally invasive procedures that rely on heart-lung machines, are expanding the indications for their use, making heart surgery a viable option for a broader range of patients. Furthermore, ongoing improvements in the safety and efficiency of these machines are encouraging their adoption in more hospitals and surgical centers worldwide. These trends underscore the crucial role of heart-lung machines in contemporary healthcare and their growing importance in meeting the needs of an aging population with increasing cardiac care demands.

SCOPE OF STUDY:

The report analyzes the Heart-Lung Machines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Component (Oxygenators Component, Pumps Component, Cannula Component, Heat Exchanger Units Component, Blood Reservoir Component, Monitoring Systems Component, Other Components); Application (Coronary Artery Bypass Grafting (CABG) Application, Heart Valve Surgeries Application, Heart Transplant Application, Lung Transplant Application, Other Applications); End-Use (Hospitals End-Use, Cardiac Centers End-Use, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 44 Featured) -

• Century HLM, LLC
• Elmeditec GmbH
• Getinge AB (Getinge Group)
• Jarvik Heart, Inc.
• LivaNova PLC
• MCA IngAcenierie
• Medtronic Plc
• Senko Medical Instrument Mfg. Co., Ltd. (MERA)
• Swanston Med LLC
• Technowood Group

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.